Company news
Quest Pharmatech Inc. (TSXV:QPT) news
Quest Pharmatech Inc. news releases on 6ix. Latest, Feb 2, 2009: Quest PharmaTech Announces a Review of Strategic Alternatives to Enhance Shareholder Value
Press releases — page 3
Quest PharmaTech Announces a Review of Strategic Alternatives to Enhance Shareholder Value
February 2, 2009
Quest PharmaTech Announces Third Financial Quarter Results and Provides Corporate Update
December 18, 2008
Quest PharmaTech Announces Interim Results from Phase I/II Clinical Trial for Photodynamic Treatment for Hair Removal
June 25, 2008
Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis
June 2, 2008
Quest PharmaTech announces 2008 financial and operational results
May 15, 2008
Quest PharmaTech Signs Agreement to sell Bionex Technology
May 7, 2008
Quest PharmaTech Receives Support from National Research Council's Industrial Research Assistance Program (NRC-IRAP) to develop Ultrasound Technology for the Treatment of Cancer
April 22, 2008
Quest PharmaTech Grants a Six Month Extension to the Terms of the Company's Outstanding Share Purchase Warrants
February 27, 2008
Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
January 28, 2008
Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
December 17, 2007
Quest PharmaTech Announces Closing of Private Placement and Provides other Corporate Updates
November 29, 2007
Quest PharmaTech Engages AMC Technologies Corp. for Development of Home Use, Light Delivery Device for Hair Removal Application with SL017
July 10, 2007
Quest PharmaTech Completes the Enrollment of Patients in Phase I Clinical Study of SL017 Topical Gel for Photodynamic Therapy of Actinic Keratosis
June 13, 2007
Quest PharmaTech Attracts European Investor with $750,000 Investment
May 31, 2007
Quest PharmaTech announces financial and operational results for the fiscal year ended January 31, 2007
May 25, 2007
Quest PharmaTech and Alberta Research Council form strategic alliance to develop alternate method to manufacture raw material for SonoLight Technology based products
May 23, 2007
Quest PharmaTech and Paramount BioSciences Sign Exclusive Multinational License Agreement to Develop and Commercialize SonoLight Technology for Dermatology Applications
May 14, 2007
Quest PharmaTech announces second equity investment by KMH Co. Ltd. in connection with Strategic Business Alliance to Distribute Cosmetic Hair Removal Product in Asia
May 10, 2007
Quest PharmaTech's Prostate Cancer Program Update
May 2, 2007
Quest PharmaTech Closes `Over-Subscribed' Private Placement
March 5, 2007
Quest PharmaTech Announces Proposed Private Placement
January 24, 2007
Quest PharmaTech Initiates a Fifty Patient Pivotal Clinical Trial for Cosmetic Hair Removal Applications
January 9, 2007
Quest PharmaTech Strengthens its Patent Protection for SonoLight Technology
December 5, 2006
Quest PharmaTech Completes $200,000 Equity Investment and announces Director Slate for the 2006 AGM.
October 30, 2006
Quest PharmaTech Renegotiates the Terms of the $1,000,000 Convertible Debenture and provides other Corporate updates
October 2, 2006
Quest PharmaTech and KMH Co. Form Strategic Business Alliance to Distribute Cosmetic Hair Removal Product in Asia.
September 27, 2006
Quest PharmaTech announces sale of non-core assets
August 8, 2006
Quest Pharmatech INC. announces positive Phase I clinical trial results for cosmetic hair removal application
June 20, 2006
Quest PharmaTech releases financial results for the fiscal year ended January 31, 2006
May 31, 2006
Quest PharmaTech Inc. provides clinical trial and corporate update
April 4, 2006
Quest PharmaTech Inc. Sells ACP-HIP Technology to Its Original Inventor
February 7, 2006
Quest PharmaTech Inc. Announces Management Changes
January 30, 2006
Quest PharmaTech Inc. Receives Health Canada Clearance to Initiate Phase I clinical trial for acne and cosmetic hair removal
January 11, 2006
Quest PharmaTech Releases Financial Results for the Nine Months Ended October 31, 2005
December 20, 2005
Quest PharmaTech Inc. expands its product pipeline to include cosmetic applications
November 9, 2005
Quest PharmaTech Inc. (formerly Altachem Pharma Ltd) - Name change
October 5, 2005
Standard & Poor's Announces Changes in the S&P/TSX Venture Composite Index
October 4, 2005
Altachem Pharma Ltd. - Corporate Update
September 26, 2005
Altachem shareholders approve resolutions at the company's September 15, 2005 annual general meeting
September 19, 2005
Altachem Pharma Ltd. completes collapse of a Chinese subsidiary
September 15, 2005
Altachem Pharma releases financial results for the six months ended July 31, 2005
September 13, 2005
Altachem signs collaborative agreement with Korean research institute
September 8, 2005
Altachem Pharma Ltd. Receives Health Canada Clearance to Initiate Phase I clinical trial for Actinic Keratosis
September 1, 2005
Altachem Pharma Ltd. announces reconstituted Scientific Advisory Board
August 24, 2005
Altachem's Bionex validated as a hand gel disinfectant
August 22, 2005
Altachem Pharma Ltd. announces director slate
August 10, 2005
Altachem Pharma releases financial results for the quarter ended April 30, 2005
June 29, 2005
Altachem Pharma releases financial results for the year ended January 31, 2005
June 1, 2005
Altachem Pharma Ltd. announces closure of Private Placement and provides corporate update
May 10, 2005